Abstract:NPMc+ and FLT3-ITD are the most frequently co-occurring mutations in Acute Myeloid Leukemia (AML). Cellular and molecular mechanisms of their cooperation are largely unknown. We investigated their effects on pre-leukemic and leukemic hematopoietic stem cells (HSCs) in mouse models that recapitulate the human disease. Both oncogenes increase proliferation of pre-leukemia HSCs, however, only NPMc+ extends self-renewal, by preventing depletion of quiescent HSCs. Quiescent HSCs include dormant and active HSCs, which are dynamic and alternative phenotypic states supporting, respectively, self-renewal and regenerative haematopoiesis. Analyses of the dormant and active transcriptional programs showed that NPMc+ stimulates the dormant-to-active transition but also enforces dormancy, thus allowing dormant HSCs to be replenished. Co-expression of NPMc+ and Flt3-ITD induces a new phenotypic state of quiescent HSCs whereby dormancy and activity co-exist at single-cell level. This new state likely supports in vivo proliferation of self-renewing HSCs and rapid selection of leukemia initiating cells. Pharmacological inhibition of the TGFb cell-dormancy pathway reduces self-renewal of leukemia SCs and prolongs mouse survival allowing to conclude that enforcement of HSC dormancy is a critical determinant of unrestricted self-renewal during leukemia development and represents a target for novel anti-leukemic strategies.

NPMc+ and Flt3-ITD cooperation promotes a new oncogenic HSC state that supports transformation and leukemia stem cell maintenance